Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hydrocortisone for early bronchopulmonary dysplasia in very preterm infants
ChiCTR1900021854Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydrocortisone in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: Survival without moderate or severe bronchopulmonary dysplasia. Started Aug 2019; status: recruiting.
02
Drugs
hydrocortisone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on ChiCTR1900021854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021854.